About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
With Americans concerned about the rising cost of health care, there is growing scrutiny on Capitol Hill of the various practices in the biopharmaceutical supply chain and how they contribute to costs. On May 3, 2018, POLITICO – in partnership with PhRMA – brought together leaders from across the biopharmaceutical supply chain for a conversation about what can be done to better control costs.
Speakers
- Gerard Anderson, Professor of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health
- Anthony Barrueta, Senior Vice President, Government Relations, Kaiser Permanente
- Kristin Bass, Senior Vice President, Policy and Federal Affairs, Pharmaceutical Care Management Association
- Stacie Maass, Senior Vice President, Pharmacy Practice and Government Affairs, American Pharmacists Association
- Ian Read, CEO, Pfizer
- Angus Worthing, M.D., Partner, Arthritis & Rhumatism Associates PC; Clinical Assistant Prof., Georgetown University Medical Center
Where
The Newseum, 8th Floor
555 Pennsylvania Avenue, NW
Washington, DC
When
Thursday, May 3, 2018
Doors open at 8:30 AM
Event
Cost and Value
Deconstructing the Prescription Drug Supply Chain
Deconstructing the Prescription Drug Supply Chain image